Marth K - Search Results

1

Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics.

Renner A, Marth K, Patocka K, Idzko M, Pohl W. Renner A, et al. Among authors: marth k. Allergy. 2020 Dec;75(12):3272-3275. doi: 10.1111/all.14441. Epub 2020 Jul 23. Allergy. 2020. PMID: 32526056 No abstract available.

2

Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.

Marth K, Schuller E, Pohl W. Marth K, et al. Respir Med. 2015 May;109(5):616-24. doi: 10.1016/j.rmed.2015.02.004. Epub 2015 Feb 18. Respir Med. 2015. PMID: 25796962 Free article.

3

Treatment response according to small airway phenotypes: a real-life observational study.

Marth K, Spinola M, Kisiel J, Woergetter C, Petrovic M, Pohl W. Marth K, et al. Ther Adv Respir Dis. 2016 Jun;10(3):200-10. doi: 10.1177/1753465816642635. Epub 2016 Apr 8. Ther Adv Respir Dis. 2016. PMID: 27060186 Free PMC article.

4

Reslizumab in an invasively ventilated patient with acute respiratory failure.

Renner A, Marth K, Schäffl-Doweik L, Pohl W. Renner A, et al. Among authors: marth k. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2922-2923. doi: 10.1016/j.jaip.2019.05.019. Epub 2019 May 25. J Allergy Clin Immunol Pract. 2019. PMID: 31136820 No abstract available.

5

Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands.

Renner A, Romanova J, Ferko B, Schmutz H, Nebolsin V, Müller M, Badorrek P, Marth K, Pohl W. Renner A, et al. Among authors: marth k. Pulm Pharmacol Ther. 2019 Dec;59:101852. doi: 10.1016/j.pupt.2019.101852. Epub 2019 Oct 6. Pulm Pharmacol Ther. 2019. PMID: 31597083 Clinical Trial.

6

COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.

Renner A, Marth K, Patocka K, Pohl W. Renner A, et al. Among authors: marth k. J Asthma. 2021 Sep;58(9):1270-1272. doi: 10.1080/02770903.2020.1781165. Epub 2020 Jun 18. J Asthma. 2021. PMID: 32519921

7

Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data.

Renner A, Marth K, Patocka K, Idzko M, Pohl W. Renner A, et al. Among authors: marth k. Pulm Pharmacol Ther. 2020 Oct;64:101946. doi: 10.1016/j.pupt.2020.101946. Epub 2020 Sep 17. Pulm Pharmacol Ther. 2020. PMID: 32949705

8

COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth.

Renner A, Marth K, Patocka K, Idzko M, Pohl W. Renner A, et al. Among authors: marth k. ERJ Open Res. 2020 Nov 2;6(4):00457-2020. doi: 10.1183/23120541.00457-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33257916 Free PMC article.

9

TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD.

Marth K, Renner A, Pohl W. Marth K, et al. Respir Med. 2021 Jun;182:106398. doi: 10.1016/j.rmed.2021.106398. Epub 2021 Apr 14. Respir Med. 2021. PMID: 33901786 Free article.

10

Dupilumab rapidly improves asthma control in predominantly anti-IL5/IL5R pretreated Austrian real-life severe asthmatics.

Renner A, Marth K, Patocka K, Idzko M, Pohl W. Renner A, et al. Among authors: marth k. Immun Inflamm Dis. 2021 Sep;9(3):624-627. doi: 10.1002/iid3.434. Epub 2021 May 7. Immun Inflamm Dis. 2021. PMID: 33960689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters